Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Children Exposed To Antipsychotic Drugs May Be More Likely To Develop Type 2 Diabetes

(Medical-NewsWire.com, February 04, 2016 ) New York, NY -- Antipsychotics Juvenile Type-2 Diabetes Lawsuit Info: Children who took prescription antipsychotic medication were at twice the risk of developing type 2 diabetes compared to youth who had mental health issues but did not take antipsychotic medication, according to the analysis published on January 20 in the online JAMA Psychiatry medical journal. One analysis involving 10 studies found males were more at risk for developing type 2 diabetes than females, and youth are more at risk when they take olanzapine (Zyprexa) or are prescribed antipsychotic drugs over a long period of time. Conversely, youth diagnosed with autism spectrum disorder had a lower type 2 diabetes risk, the study showed.

[ http://archpsyc.jamanetwork.com/article.aspx?articleid=2483011, JAMA Psychiatry, January 20, 2016 ]



Alonso Krangle LLP Is Investigating Antipsychotic Drug (Abilify, risperdal, Zyprexa, Seroquel) Childhood Type 2 Diabetes Lawsuit Evaluations Of Children Who Developed Type 2 Diabetes While Using Prescription Antipsychotic Medication. Victims of type 2 diabetes should consult with an experienced defective drug lawyer at Alonso Krangle LLP as soon as possible to learn about their legal rights and to maximize their chance at recovery. Alonso Krangle offers free antipsychotic drug (Abilify, Risperdal, Zyprexa, Seroquel) Childhood Type 2 Diabetes lawsuit evaluations. To discuss a potential antipsychotic drug (Abilify, Risperdal, Zyprexa, Seroquel) Childhood Type 2 Diabetes lawsuit claim, please contact us at 1-800-403-6191 or visit our website, FightForVictims.com



Children Who Are Prescribed Zyprexa, Risperal, And Abilify Have Triple The Risk Of Developing Type 2 Diabetes



The recent study supports findings from Vanderbilt University where researchers there found that children who took antipsychotic drugs, such as Zyprexa, Risperal, and Abilify have triple the risk of developing type 2 diabetes compared to youth who took other drugs to treat the same medical conditions. In their 2013 study, researchers reviewed data from more than 28,000 patients from 6 to 24 years old who were enrolled in Tennessee’s Medicaid program and were prescribed Abilify, Risperdal, Seroquel and Zyprexa over a 12-year period. The study indicated that a child’s risk for type 2 diabetes was present almost immediately within the first year of the child taking the antipsychotic medication, and continued for one year after the child stopped taking the drugs.

[ http://archpsyc.jamanetwork.com/article.aspx?articleid=1731662, JAMA Psychiatry, October 2013 ]



What Is Type 2 Diabetes?



Diabetes is caused by the body’s inability to produce or use insulin, a hormone that controls blood sugar levels. A person’s blood sugar level becomes too high when the pancreas does not produce enough insulin or if the insulin does not function properly. Type 2 diabetes is the most common form of the medical condition. About 21 million people in the United States have been diagnosed with diabetes, according to the U.S. Centers for Disease Control (CDC) and Prevention. Diabetes can increase the risk of such serious health conditions as blindness, heart attack, nerve and kidney damage, and loss of toes or feet. Children are suffering from the disease with much greater frequency, the CDC added.



Type 2 Diabetes Antipsychotic Drug Lawsuit Legal Claims



The increase use of prescription antipsychotic drugs among children have prompted lawsuits being filed on behalf of youth who experienced devastating side effects from the medication. For instance, complaints are being filed on behalf of young males who took Risperdal allege that the drug’s maker, Johnson & Johnson failed to disclose side effects that include diabetes, weight gain and gynecomastia, which is abnormal male breast growth. The Risperdal complaints also allege that Risperdal was illegally promoted to children when its use in youth had not yet been approved by the U.S. Food and Drug Administration (FDA). The FDA did not approve Risperdal for any use in children for any purpose until 2006. In 2013, Johnson & Johnson and its Janssen Pharmaceuticals unit reached an agreement with the U.S, Department of Justice to pay more than $2.2 billion to resolve civil and criminal charges filed against the companies over misbranding Risperdal and its other drugs.

[ http://www.justice.gov/opa/pr/2013/November/13-ag-1170.html, U.S. Department of Justice, November 4, 2013 ]



If you or your child were prescribed an antipsychotic drug such as Abilify, Seroquel, Risperdal, and Zyprexa, and now suffer from type 2 diabetes, you may be entitled to recover civil damages. Victims of type 2 diabetes should consult with an experienced defective drug lawyer at Alonso Krangle LLP as soon as possible to learn about their legal rights and to maximize their chance at recovery. Alonso Krangle offers free antipsychotic drug (Abilify, Risperdal, Zyprexa, Seroquel) Childhood Type 2 Diabetes lawsuit evaluations. To discuss a potential antipsychotic drug (Abilify, Risperdal, Zyprexa, Seroquel) Childhood Type 2 Diabetes lawsuit claim, please contact us at 1-800-403-6191 or visit our website, www.FightForVictims.com

Alonso Krangle LLP

Dave Krangle

1-800-403-6191

DKrangle@alonsokrangle.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC